首页> 外文期刊>Current medical research and opinion >Postoperative analgesic requirements after subarachnoid or epidural anesthesia with ropivacaine 0.75 in cesarean section. A double-blind randomized trial
【24h】

Postoperative analgesic requirements after subarachnoid or epidural anesthesia with ropivacaine 0.75 in cesarean section. A double-blind randomized trial

机译:蛛网膜下腔或硬膜外麻醉后,在剖宫产术中使用罗哌卡因0.75进行术后镇痛。一项双盲随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Postoperative analgesic requirements and pain scores were compared after subarachnoid versus epidural anesthesia with plain ropivacaine 0.75 for elective cesarean section. Study design: Ropivacaine 0.75 was randomly administered for subarachnoid or epidural anesthesia in 108 parturients, scheduled for cesarean section. Times for the sensory block to reach T4 level and to regress to T6 level were recorded. At 2, 4, 8 and 24h postoperatively, pain scores at rest and cough, morphine consumption as well as patient satisfaction, incidence of headache, nausea and/or vomiting were measured. Results: Median (minmax) time for the sensory block to reach T4 was 7 (30) min versus 24 (1673) min and to regress to T6 was 126 (70332) min versus 200 (98439) min in the subarachnoid and epidural groups, respectively (p=0.001). Although the subarachnoid had more analgesic consumption than the epidural group at 2 and 4h postoperatively (7.3±4.7vs. 1.8±2.4mg, p=0.001 and 9±5.7vs. 3.3±3.8mg, p=0.001, respectively) no difference was observed at 8 or 24h postoperatively (p=0.14 and p=0.38, respectively). VAS scores at rest and after cough (p=0.56, p=0.35, respectively), patient satisfaction (p=0.61), incidence of headache (p1.0), nausea and/or vomiting (p=0.78) did not differ between the two groups. Conclusions: Postoperative pain, analgesic requirements, patient satisfaction and adverse effects did not differ when subarachnoid or epidural anesthesia with ropivacaine 0.75 was used for elective cesarean section. Nevertheless, subarachnoid provides faster onset and offset of the block, compared to epidural anesthesia. The key limitation of this study is the lack of postoperative serum ropivacaine measurements taken with concurrent pain score measurements.
机译:目的:比较蛛网膜下腔麻醉与硬膜外麻醉联合罗哌卡因0.75选择性麻醉剖宫产术后的镇痛要求和疼痛评分。研究设计:罗非卡因0.75随机分配用于108例剖宫产的蛛网膜下腔或硬膜外麻醉。记录感觉阻滞达到T4水平并退回到T6水平的时间。术后第2、4、8和24小时,测量休息和咳嗽时的疼痛评分,吗啡的消耗量以及患者的满意度,头痛,恶心和/或呕吐的发生率。结果:到达蛛网膜下腔和硬膜外组的感觉阻滞到达T4的中位(minmax)时间为7(30)分钟,而24(1673)分钟为回归至T6的时间为126(70332)min,而蛛网膜下腔和硬膜外组为200(98439)min。分别为(p = 0.001)。尽管蛛网膜下腔手术后2h和4h的镇痛消耗量比硬膜外组多(分别为7.3±4.7vs。1.8±2.4mg,p = 0.001和9±5.7vs。3.3±3.8mg,p = 0.001),但无差异术后8或24小时观察到(分别为p = 0.14和p = 0.38)。静息和咳嗽后的VAS评分(分别为p = 0.56,p = 0.35),患者满意度(p = 0.61),头痛的发生率(p1.0),恶心和/或呕吐(p = 0.78)之间无差异两组。结论:蛛网膜下腔或硬膜外麻醉联合罗哌卡因0.75用于选择性剖宫产时,术后疼痛,镇痛要求,患者满意度和不良反应无差异。然而,与硬膜外麻醉相比,蛛网膜下腔提供了更快的阻滞发作和偏移。该研究的主要局限性是缺乏同时进行疼痛评分测量的术后血清罗哌卡因测量值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号